CellerateRX® Gel
Surgical/Wound Management
ApprovedCommercial
Key Facts
About Sanara MedTech
Sanara MedTech is a medical technology company with a mission to improve patient outcomes through advanced healing solutions. The company has a diversified commercial portfolio of surgical biologics and is pioneering a novel bone bioadhesive technology, OsStic™, which received FDA Breakthrough Device Designation in 2023. With a focus on the surgical and orthopedic markets, Sanara leverages clinical education and research to drive adoption of its products.
View full company profileTherapeutic Areas
Other Surgical/Wound Management Drugs
| Drug | Company | Phase |
|---|---|---|
| CellerateRX® Surgical Powder | Sanara MedTech | Approved |